Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OligoProgressive Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06367972
What this trial is testing

Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

Who this might be right for
OligoProgressive Metastatic Disease
M.D. Anderson Cancer Center 400
Not applicableLooking for participantsNCT06925984
What this trial is testing

Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)

Who this might be right for
OligoProgressive Metastatic Disease
Jules Bordet Institute 48
Testing effectiveness (Phase 2)Looking for participantsNCT04299646
What this trial is testing

A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

Who this might be right for
Metastatic Renal Cell CarcinomaRadiotherapy
Centre Francois Baclesse 77
Not applicableActive Not RecruitingNCT06055881
What this trial is testing

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

Who this might be right for
Breast CarcinomaAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Cancer
Mayo Clinic 45
Not applicableLooking for participantsNCT05784428
What this trial is testing

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Who this might be right for
Oligometastatic DiseaseOligoprogressionToxicity Due to Radiotherapy+1 more
Robert Olson 598
Testing effectiveness (Phase 2)Active Not RecruitingNCT04070209
What this trial is testing

Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital 66
Not applicableLooking for participantsNCT04115254
What this trial is testing

Stereotactic Magnetic Resonance Guided Radiation Therapy

Who this might be right for
Pancreas CancerLung CancerRenal Cancer+10 more
Dana-Farber Cancer Institute 397
Not applicableLooking for participantsNCT05102747
What this trial is testing

Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.

Who this might be right for
Brain MetastasisOligoprogression
Centre Francois Baclesse 504
Early research (Phase 1)Looking for participantsNCT07619599
What this trial is testing

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainOligoprogressive Lung Non-Small Cell Carcinoma+1 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT06927635
What this trial is testing

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

Who this might be right for
Castrate Resistance Prostate CancerOligoProgressive Metastatic Disease
University Health Network, Toronto 75
Testing effectiveness (Phase 2)Looking for participantsNCT06601296
What this trial is testing

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma ( mRCC)OligoProgressive Metastatic Disease
University of Texas Southwestern Medical Center 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06813664
What this trial is testing

CtDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung CancerOligoProgressive Metastatic Disease
University Health Network, Toronto 60